PremiumThe FlyImunon to present translational data in supporting Phase 2 OVATION Study Imunon Announces Private Placement Agreement with Investors 3 Penny Stocks to Watch Now, 5/27/25 PremiumThe FlyImunon announces withdrawal of Form S-1 Registration Statement Imunon Withdraws Registration Statement Impacting Strategy Imunon Receives Nasdaq Non-Compliance Notice PremiumRatingsPositive Outlook on Imunon Driven by Advancements in OVATION 3 Study and Strategic Focus on HRD+ Patients IMUNON, Inc. Reports Q1 2025 Financial Results and Clinical Progress Imunon, Inc. Earnings Call: Clinical Progress Amid Financial Challenges 
